K-RITH is a vibrant and growing research organisation with a diverse staff committed to the mission of advancing science toward the control of HIV and tuberculosis.

K-RITH’s director, William Bishai, leads the institute and oversees its scientific and educational programmes. The director is assisted by a Chief Operating Officer, Costas Criticos, who manages the institute's finances, human resources, procurement, information technology, and building management. 

Research programmes at K-RITH are headed by assistant, associate, and full investigators. K-RITH has capacity for between six and nine research teams. Core research facilities dedicated to microbiology, immunology, pharmacology, high-throughput biology, and coordination of clinical research support their work.

K-RITH’s education and training programme, led by Victoria Kasprowicz, has already presented workshops and symposia to help train the next generation of HIV and TB researchers. The programme will eventually include research training for graduate students and postdoctoral fellows, workshops, symposia, and travel grants.

K-RITH is governed by a board of directors composed of outstanding scientific and global health leaders. The board of directors, chaired by Alan Aderem, meets twice yearly to review and authorize K-RITH appointments, major financial initiatives, and collaborations. Its scientific advisory board, chaired by Barry Bloom, is composed largely of international experts in HIV and TB research. It meets semiannually to advise the director and the science programmes at K-RITH.